https://www.qandqmarketresearch.com/reports/7143036/antimycobacterial-drugs-market-92
Antimycobacterial drugs are used to treat infections caused by members of Mycobacterium genus. Mycobacterium genus includes M. tuberculosis, M. leprae, and M. aviumintracellulare which cause tuberculosis, leprosy, and atypical mycobacteria, respectively.
The hospital pharmacies segment dominated the antimycobacterial drugs market in 2017 due to easy availability of leprosy and tuberculosis medications in government hospitals. The segment is expected to continue to dominate the market from 2018 to 2025.
In 2017, the global Antimycobacterial Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 20182025.

This report focuses on the global Antimycobacterial Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antimycobacterial Drugs development in United States, Europe and China.

The key players covered in this study
Pfizer
Novartis
GlaxoSmithKline
Bayer
AstraZeneca
Sanofi
Merck
Lupin
Macleods Pharmaceuticals
Systopic Laboratories
Zydus Cadila

Market segment by Type, the product can be split into
Drugs Used for Tuberculosis
Drugs Used for Leprosy
Drugs Used for Atypical Mycobacteria

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Antimycobacterial Drugs status, future forecast, growth opportunity, key market and key players.
To present the Antimycobacterial Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Antimycobacterial Drugs are as follows:
History Year: 20132017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.